Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:antilipemic agent
go back to main search page
Accession:XCO:0000680 term browser browse the term
Definition:This is any condition in which the main influencing factor is a substance used to treat hyperlipidemia (an excess of lipids in the blood).
Synonyms:exact_synonym: antilipemic drug
 alt_id: CHEBI:35679



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 0
    therapeutic agent 0
      antilipemic agent 0
        Benfluorex 0
        Medica 16 0
        Omacor 0
        atorvastatin 0
        cholestyramine 0
        clofibrate 0
        diallyl trisulfide 0
        fenofibrate 0
        hawk tea extract + 0
Path 2
Term Annotations click to browse term
  experimental condition 0
    chemical 0
      chemical with specified function 0
        antilipemic agent 0
          Benfluorex 0
          Medica 16 0
          Omacor 0
          atorvastatin 0
          cholestyramine 0
          clofibrate 0
          diallyl trisulfide 0
          fenofibrate 0
          hawk tea extract + 0
paths to the root